Science and Enterprise

Category: Joint ventures/collaborations

  • Biotech Company, University to Partner on Polymers

    Kraig Biocraft Laboratories Inc., a biotechnology company in Lansing, Michigan confirmed that the company entered into a collaborative research and development agreement with the University of Notre Dame in South Bend, Indiana for the development of new polymers. Polymers are molecules strung in long repeating chains that are found in a host of natural and…

  • Venture to Produce Membranes for Hydrogen Separation, CO2 Capture

    Eltron Research & Development Inc. in Boulder, Colorado and Eastman Chemical Company in Kingsport, Tennessee have agreed to jointly scale up and pilot test Eltron’s membrane system for hydrogen separation and carbon dioxide (CO2) capture. The $8 million project is funded by the U.S. Department of Energy. Eltron’s metallic membrane system extracts pure hydrogen from…

  • University-Business Partners Get Grant for Energy Project

    MTECH Laboratories in Ballston Spa, New York has received a Small Business Innovation Research grant from National Science Foundation to demonstrate the feasibility of its energy distribution system for large buildings. The grant funds joint research and development on power distribution with the nearby College of Nanoscale Science and Engineering of the University at Albany,…

  • Instrumention, Engineering Firms Produce Immunoassay Platform

    Bodkin Design & Engineering in Wellesley Hills, Massachusetts, with Boston University and Zoíray Technologies, also in Boston, have developed a commercial instrument based on the partners’ basic research. The product, the Spectral Reflectance Imaging Biosensor (SRIB), is a multiplexed immunoassay platform for life science research and clinical diagnostics. Immunoassays are chemical tests used to detect…

  • Biotech Company to Partner with Scripps on Parkinson’s Drugs

    Envoy Therapeutics Inc., a drug discovery company in Jupiter, Florida says it has begun a research collaboration with The Scripps Research Institute to identify new drugs for Parkinson’s disease that have greater efficacy and safety compared to current therapies. Using funding provided by Envoy, scientists at the two organizations will apply Scripps-Florida’s screening facilities —…

  • Max Planck to License Peptide for Cytoskeleton Research

    The Max Planck Society, through its technology transfer affiliate Max Planck Innovation GmbH in Munich, Germany, has awarded an exclusive license for the peptide LifeAct to ibidi GmbH, a provider of cell analysis products, located in Martinsried, Germany. The peptide allows for actin, an important protein in a cell’s cytoskeleton, to be made visible in…

  • Collaboration Improves Filters for Storm Water Runoff

    A group of scientists from the Agricultural Research Service (ARS) in the U.S. Department of Agriculture and Filtrexx International of Grafton, Ohio, have improved on the methods for removing contaminants from storm water runoff. The runoff from storm water is particularly vulnerable to pollution in industrial areas or near construction sites. Current methods use “filter…

  • Energy Department Helps Fund Six CO2 Capture Pilot Projects

    The U.S. Department of Energy (DoE) will help fund six projects that aim to convert captured carbon dioxide (CO2) emissions from industrial sources into useful products such as fuel, plastics, cement, and fertilizers.  DoE will contribute $106 million in American Recovery and Reinvestment Act funds, combined with $156 million in private cost sharing. The projects…

  • GE, Sloan-Kettering to Study Early Stage Colon Cancer

    A team of scientists at GE Global Research, the technology development arm of the manufacturing and finance company GE, has begun a study with Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, N.Y., to better understand the early stages of colon cancer. The goal is to yield new insights that improve treatment selection and outcomes…

  • Partnership to Identify Targets for Neurological Diseases

    The Gladstone Institutes in San Francisco, California and the pharmaceutical company H. Lundbeck A/S of Copenhagen, Denmark have agreed to study and identify therapeutic candidates for neurological diseases. The agreement funds research at the Gladstone Center for Translational Research led by Gladstone investigator Katerina Akassoglou, and establishes the new Lundbeck Center for Neurovascular and Immunoimaging…